• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Suez Canal University Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 28 (2025)
Volume Volume 27 (2024)
Volume Volume 26 (2023)
Volume Volume 25 (2022)
Volume Volume 24 (2021)
Volume Volume 23 (2020)
Volume Volume 22 (2019)
Volume Volume 21 (2018)
Volume Volume 20 (2017)
Issue Issue 2
Issue Issue 1
Volume Volume 19 (2016)
Volume Volume 18 (2015)
Volume Volume 17 (2014)
Volume Volume 16 (2013)
Volume Volume 15 (2012)
Volume Volume 14 (2011)
Volume Volume 13 (2010)
Hassoba, H., Salama, M. (2017). Regulatory T Cells in Health and Disease. Suez Canal University Medical Journal, 20(1), 1-10. doi: 10.21608/scumj.2017.46082
Howayda M. Hassoba; Mona I. Salama. "Regulatory T Cells in Health and Disease". Suez Canal University Medical Journal, 20, 1, 2017, 1-10. doi: 10.21608/scumj.2017.46082
Hassoba, H., Salama, M. (2017). 'Regulatory T Cells in Health and Disease', Suez Canal University Medical Journal, 20(1), pp. 1-10. doi: 10.21608/scumj.2017.46082
Hassoba, H., Salama, M. Regulatory T Cells in Health and Disease. Suez Canal University Medical Journal, 2017; 20(1): 1-10. doi: 10.21608/scumj.2017.46082

Regulatory T Cells in Health and Disease

Article 1, Volume 20, Issue 1, March 2017, Page 1-10  XML PDF (841.02 K)
Document Type: Original Article
DOI: 10.21608/scumj.2017.46082
View on SCiNiTO View on SCiNiTO
Authors
Howayda M. Hassoba email orcid 1; Mona I. Salama2
1Clinical Pathology Department, Faculty of Medicine, Suez Canal University
2Department of Clinical Pathology, Faculty of Medicine, Port Said University, Egypt
Abstract
CD4+ T cells are commonly divided into regulatory T (Treg) cells and conventional T helper (Th) cells. Th cells control adaptive immunity against pathogens and cancer by activating other effector immune cells. Treg cells are defined as CD4+ T cells in charge of suppressing potentially deleterious activities of Th cells. Suggested functions for Treg cells include: prevention of autoimmune diseases by maintaining self-tolerance; suppression of allergy, asthma and pathogeninduced immunopathology; feto-maternal tolerance; and oral tolerance. Identification of Treg cells remains problematic, because accumulating evidence suggests that all the presently-used Treg markers (CD25, CTLA-4, GITR, LAG-3, CD127 and Foxp3) represent general T-cell activation markers, rather than being truly Treg-specific. Treg-cell activation is antigen-specific, which implies that suppressive activities of Treg cells are antigen-dependent. The classification of Treg cells as a separate lineage remains controversial because the ability to suppress is not an exclusive Treg property. Suppressive activities attributed to Treg cells may in reality, at least in some experimental settings, be exerted by conventional Th cell subsets, such as Th1, Th2, Th17 and T follicular (Tfh) cells. Recent reports have also demonstrated that Foxp3+ Treg cells may differentiate in vivo into conventional effector Th cells, with or without concomitant down regulation of Foxp3
Keywords
foxp3; immunity; Autoimmunity
Statistics
Article View: 212
PDF Download: 449
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.